Nawal Ouzren Chief Executive Officer to step down for personal reasons Amit Munshi, Chairman of Sensorion to assume role of Interim CEO MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced that Nawal Ouzren, … [Read more…]
Gross sales of TWYMEEG® in Japan continued to accelerate, increasing by 15.0% in the fourth quarter of 2025 (October–December) compared with the previous quarter, and by 40% compared with the fourth quarter of 2024. Poxel generated revenue of €5.0 million for the year ended 31 December 2025 corresponding to 10% royalties on TWYMEEG net sales … [Read more…]
Partnership improves access to great dermatologic care AUSTIN, Texas–(BUSINESS WIRE)–Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in Missouri through its partnership with Regional Dermatology, LLC. Founded in 2010 by Sarah Jensen, M.D., Regional Dermatology has a long-established reputation of providing high-quality … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–#MRD–A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe’s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a … [Read more…]
Genetic complexity of wheat has long thwarted efforts to hybridize wheat, to realize the benefits of improved yield and the combination of beneficial traits X-Terra® is Europe’s first commercially scalable hybrid wheat BASEL, Switzerland–(BUSINESS WIRE)–Wheat is the world’s most genetically complex staple crop, with the wheat genome nearly six times the size of the human … [Read more…]
– MAJESTY, the first global Phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years – – Up to 30% of people with membranous nephropathy progress to kidney failure over 10 years despite current treatment approaches; achieving complete remission can help delay or prevent this – – Gazyva … [Read more…]
OAKLAND, Calif.–(BUSINESS WIRE)–#COVID19–After surging during the height of the COVID-19 pandemic, the number of nonfatal work injuries and illnesses in California returned to pre-pandemic levels in 2024 according to a California Workers’ Compensation Institute (CWCI) review of data from the California Department of Industrial Relations (DIR) Director’s Office of Research. Recent results from California’s Survey … [Read more…]
Veteran nurse and healthcare executive brings heart-centered leadership, and operational excellence to advance the lifesaving work of LifeLink ATLANTA–(BUSINESS WIRE)–#donor—LifeLink Foundation today announced that Kelly Cullen, RN, MBA, has joined the organization as Chief Operating Officer (COO) to support the mission and continued growth of LifeLink. Cullen will provide strategic and operational leadership to advance … [Read more…]
Planned funding cuts by the provincial government will lengthen wait-times and worsen patient care in hospitals, warns CUPE OTTAWA–(BUSINESS WIRE)–As hospitals cut hundreds of jobs and eliminate vacant positions amidst budgetary constraints imposed by the Conservative government, the largest health care union in Ontario is warning about longer wait-times, rushed care, preventable mistakes, and overcrowded … [Read more…]
WILMINGTON, Del.–(BUSINESS WIRE)–Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) demonstrated statistically significant and clinically meaningful improvements in patients with uncontrolled asthma compared with dual-combination inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) medicines: Symbicort (budesonide/formoterol fumarate or BFF, a standard … [Read more…]
